Singh Sudhir, Simpson Ronda L, Bennett Robert G
From the Medical Research Service, The Department of Veterans Affairs, Nebraska-Western Iowa Health Care System, Omaha, Nebraska 68105 and the Departments of Biochemistry & Molecular Biology, Internal Medicine and Pharmacology & Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska 68198.
From the Medical Research Service, The Department of Veterans Affairs, Nebraska-Western Iowa Health Care System, Omaha, Nebraska 68105 and the Departments of Biochemistry & Molecular Biology, Internal Medicine and Pharmacology & Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska 68198
J Biol Chem. 2015 Jan 9;290(2):950-9. doi: 10.1074/jbc.M114.589325. Epub 2014 Nov 11.
Relaxin activation of its receptor RXFP1 triggers multiple signaling pathways. Previously, we have shown that relaxin activates PPARγ transcriptional activity in a ligand-independent manner, but the mechanism for this effect was unknown. In this study, we examined the signaling pathways of downstream of RXFP1 leading to PPARγ activation. Using cells stably expressing RXFP1, we found that relaxin regulation of PPARγ activity requires accumulation of cAMP and subsequent activation of cAMP-dependent protein kinase (PKA). The activated PKA subsequently phosphorylated cAMP response element-binding protein (CREB) at Ser-133 to activate it directly, as well as indirectly through mitogen activated protein kinase p38 MAPK. Activated CREB was required for relaxin stimulation of PPARγ activity, while there was no evidence for a role of the nitric oxide or ERK MAPK pathways. Relaxin increased the mRNA and protein levels of the coactivator protein PGC1α, and this effect was dependent on PKA, and was completely abrogated by a dominant-negative form of CREB. This mechanism was confirmed in a hepatic stellate cell line stably that endogenously expresses RXFP1. Reduction of PGC1α levels using siRNA diminished the regulation of PPARγ by relaxin. These results suggest that relaxin activates the cAMP/PKA and p38 MAPK pathways to phosphorylate CREB, resulting in increased PGC1α levels. This provides a mechanism for the ligand-independent activation of PPARγ in response to relaxin.
松弛素对其受体RXFP1的激活会触发多种信号通路。此前,我们已经表明松弛素以不依赖配体的方式激活PPARγ转录活性,但其作用机制尚不清楚。在本研究中,我们研究了RXFP1下游导致PPARγ激活的信号通路。利用稳定表达RXFP1的细胞,我们发现松弛素对PPARγ活性的调节需要cAMP的积累以及随后cAMP依赖性蛋白激酶(PKA)的激活。激活的PKA随后在Ser-133位点磷酸化cAMP反应元件结合蛋白(CREB)以直接激活它,同时也通过丝裂原活化蛋白激酶p38 MAPK间接激活。激活的CREB是松弛素刺激PPARγ活性所必需的,而没有证据表明一氧化氮或ERK MAPK信号通路发挥作用。松弛素增加了辅激活蛋白PGC1α的mRNA和蛋白水平,这种作用依赖于PKA,并且被显性负性形式的CREB完全消除。在稳定内源性表达RXFP1的肝星状细胞系中证实了这一机制。使用小干扰RNA降低PGC1α水平减少了松弛素对PPARγ的调节。这些结果表明,松弛素激活cAMP/PKA和p38 MAPK信号通路使CREB磷酸化,导致PGC1α水平升高。这为响应松弛素时PPARγ的非配体依赖性激活提供了一种机制。